• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎及其他脂肪性肝病的发病机制:一个包含脂质释放及肝小静脉阻塞在肝硬化进展中的作用的四步模型。

The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

作者信息

Wanless Ian R, Shiota Koji

机构信息

Department of Pathology, University Health Network-Toronto General Hospital, Toronto, Canada.

出版信息

Semin Liver Dis. 2004 Feb;24(1):99-106. doi: 10.1055/s-2004-823104.

DOI:10.1055/s-2004-823104
PMID:15085490
Abstract

Fatty liver disease involves the accumulation of triglycerides in hepatocytes, necrosis of hepatocytes, inflammation, and often fibrosis with progression to cirrhosis. The two-hit model summarizes the important early metabolic events leading to hepatocellular necrosis in nonalcoholic steatohepatitis (NASH). In this article, we provide evidence of lipid release from hepatocytes in posttransplant fat necrosis and in NASH and quantify vascular obliteration in a series of biopsies with NASH. Obliteration of small hepatic veins (<30 microm) in small numbers is compensated by collateral flow. Obliteration of larger hepatic veins (>30 microm) is associated with fibrotic collapse lesions that are not easily resorbed. Based on these observations, we propose a new four-step model that includes the later events that lead to cirrhosis after necrosis has occurred. This model is applicable to nonalcoholic fatty liver disease (NAFLD), alcoholic disease, postjejunoileal bypass disease, and posttransplant fat necrosis. The first step is steatosis facilitated by insulin, and the second is necrosis induced by intracellular lipid toxicity or lipid peroxidation, or both, modified by alcohol, drugs, and ischemia. The third step is release of bulk lipid from hepatocytes into the interstitium leading to direct and inflammatory injury to hepatic veins. The fourth step is venous obstruction with secondary collapse and ultimately fibrous septation and cirrhosis.

摘要

脂肪性肝病涉及肝细胞内甘油三酯的积累、肝细胞坏死、炎症,且常伴有纤维化并进展为肝硬化。双打击模型总结了导致非酒精性脂肪性肝炎(NASH)肝细胞坏死的重要早期代谢事件。在本文中,我们提供了移植后脂肪坏死和NASH中肝细胞脂质释放的证据,并对一系列NASH活检中的血管闭塞情况进行了量化。少量小肝静脉(<30微米)闭塞可通过侧支循环代偿。较大肝静脉(>30微米)闭塞与不易吸收的纤维化塌陷病变相关。基于这些观察结果,我们提出了一个新的四步模型,该模型包括坏死发生后导致肝硬化的后续事件。此模型适用于非酒精性脂肪性肝病(NAFLD)、酒精性疾病、空肠回肠旁路术后及移植后脂肪坏死。第一步是由胰岛素促进的脂肪变性,第二步是由细胞内脂质毒性或脂质过氧化或两者共同诱导的坏死,酒精、药物和缺血可对其进行修饰。第三步是大量脂质从肝细胞释放到间质中,导致肝静脉直接损伤和炎性损伤。第四步是静脉阻塞伴继发性塌陷,最终形成纤维间隔和肝硬化。

相似文献

1
The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.非酒精性脂肪性肝炎及其他脂肪性肝病的发病机制:一个包含脂质释放及肝小静脉阻塞在肝硬化进展中的作用的四步模型。
Semin Liver Dis. 2004 Feb;24(1):99-106. doi: 10.1055/s-2004-823104.
2
[Nonalcoholic steatohepatitis--a "new" hepatic disease].非酒精性脂肪性肝炎——一种“新型”肝脏疾病
Ugeskr Laeger. 2003 Mar 10;165(11):1115-8.
3
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.非酒精性脂肪性肝炎中的进行性纤维化:与再生改变和小胆管反应的关联。
Gastroenterology. 2007 Jul;133(1):80-90. doi: 10.1053/j.gastro.2007.05.012. Epub 2007 May 16.
4
Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.病态肥胖患者非酒精性脂肪性肝炎和肝纤维化进展的预测因素
Obes Surg. 2005 Mar;15(3):310-5. doi: 10.1381/0960892053576820.
5
Hepatic microcirculation in fatty liver disease.脂肪性肝病中的肝微循环
Anat Rec (Hoboken). 2008 Jun;291(6):684-92. doi: 10.1002/ar.20715.
6
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
Rev Gastroenterol Disord. 2002;2(1):11-9.
7
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.病态肥胖的肝脏组织病理学:其他形式慢性肝病的并发情况。
Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.
8
Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.减肥手术对非酒精性脂肪性肝病的影响:2年后的初步结果。
J Gastroenterol Hepatol. 2007 Apr;22(4):510-4. doi: 10.1111/j.1440-1746.2007.04833.x.
9
The role of the lipogenic pathway in the development of hepatic steatosis.脂肪生成途径在肝脂肪变性发展中的作用。
Diabetes Metab. 2008 Dec;34(6 Pt 2):643-8. doi: 10.1016/S1262-3636(08)74599-3.
10
Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.脂肪酸在肥胖和脂肪肝发病机制中的作用:减肥手术的影响
Semin Liver Dis. 2008 Nov;28(4):407-26. doi: 10.1055/s-0028-1091985. Epub 2008 Oct 27.

引用本文的文献

1
Diagnostic performance of microvascular flow imaging for noninvasive assessment of liver fibrosis in chronic liver disease.微血管血流成像对慢性肝病肝纤维化无创评估的诊断效能
PLoS One. 2025 Jun 4;20(6):e0322102. doi: 10.1371/journal.pone.0322102. eCollection 2025.
2
Low Aspartate Aminotransferase/Alanine Aminotransferase Ratio as an Indicator of Metabolic Syndrome Among HIV Patients on Dolutegravir Therapy in Southwestern Uganda.低天冬氨酸转氨酶/丙氨酸转氨酶比值作为乌干达西南部接受多替拉韦治疗的HIV患者代谢综合征的一个指标
Cureus. 2025 Jan 8;17(1):e77166. doi: 10.7759/cureus.77166. eCollection 2025 Jan.
3
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.
代谢相关性脂肪性肝病(MAFLD)的分子机制:脂质代谢途径的功能分析。
Clin Sci (Lond). 2022 Sep 30;136(18):1347-1366. doi: 10.1042/CS20220572.
4
Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress.辛伐他汀改善非酒精性脂肪性肝病的微循环功能并下调氧化和 ALE-RAGE 应激。
Nutrients. 2022 Feb 8;14(3):716. doi: 10.3390/nu14030716.
5
Histological assessment based on liver biopsy: the value and challenges in NASH drug development.基于肝活检的组织学评估:在 NASH 药物研发中的价值和挑战。
Acta Pharmacol Sin. 2022 May;43(5):1200-1209. doi: 10.1038/s41401-022-00874-x. Epub 2022 Feb 14.
6
Cellular Mechanisms of Liver Fibrosis.肝纤维化的细胞机制
Front Pharmacol. 2021 May 6;12:671640. doi: 10.3389/fphar.2021.671640. eCollection 2021.
7
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review.代谢综合征中非酒精性脂肪性肝病的机制。一篇叙述性综述。
Antioxidants (Basel). 2021 Feb 10;10(2):270. doi: 10.3390/antiox10020270.
8
Diabetes and liver cancer risk: A stronger effect in Whites than Blacks?糖尿病与肝癌风险:白人比黑人的影响更大?
J Diabetes Complications. 2021 Mar;35(3):107816. doi: 10.1016/j.jdiacomp.2020.107816. Epub 2020 Dec 1.
9
Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice.菊苣酸通过AMPK/Nrf2/NFB信号通路改善高脂饮食喂养小鼠的非酒精性脂肪性肝病并恢复肠道微生物群。
Oxid Med Cell Longev. 2020 Nov 3;2020:9734560. doi: 10.1155/2020/9734560. eCollection 2020.
10
Contrast-Enhanced Ultrasonography-Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure.基于超声造影的肝脏灌注对急性肝衰竭预后的早期预测。
Hepatology. 2021 Jun;73(6):2455-2467. doi: 10.1002/hep.31615. Epub 2021 May 24.